secwatch.observer — SEC 8-K summary
======================================

Issuer:     Metagenomi Therapeutics, Inc. (MGX)
CIK:        0001785279
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0001193125-24-033697
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Metagenomi adopts amended charter and bylaws in connection with IPO
-------------------------------------------------------------------

- Authorized 500M shares of common stock and 10M shares of undesignated preferred stock.
- Eliminated all references to prior series of preferred stock.
- Stockholders can no longer act by written consent or call special meetings.
- Established advance notice procedures for stockholder proposals and director nominations.
- Amendments effective upon consummation of the initial public offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1785279/000119312524033697/0001193125-24-033697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1785279/000119312524033697/d770467d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-033697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer